Related Experiment Video
Updated: Dec 15, 2025

11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
1.6K
Double-bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS-CoV-2
1Hematologia e Hemoterapia, Hospital de Clínicas, Porto Alegre, Brazil.
British Journal of Haematology
|July 10, 2020
Abstract
No abstract available in PubMed .

